Gastrodia and Uncaria Recipe in Treating Stage-one Hypertension: an Evidence-based Optimization Study

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 605 participants.

Also called NCT04035824

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 605 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04035824
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04035824. Randomized; double masking; primary purpose treatment. Start 2019-10-08 (actual); primary completion 2024-04-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Gastrodia and Uncaria Recipe in Treating Stage-one Hypertension: an Evidence-based Optimization Study
Condition
Hypertension
Intervention (Drug)
Gastrodia and Uncaria granule
Intervention (Drug)
Placebo of Gastrodia and Uncaria granule
Lead sponsor
Shanghai Institute of Hypertension (class: other)
Collaborator
Ruijin Hospital (class: other)
Collaborator
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (class: other)

Record details

Record id
cardio:ct-nct04035824
Content hash
59ea662f94a3c31f3637d6a07d37c9c80250ea959033360467b128bdade649a1